Updated Clinical Guidance For Individuals 6 Months-11 Years Old
– June 22, 2022
Dear NYS COVID-19 Vaccine Provider:
Effective June 18, 2022, the CDC has recommended that everyone ages 6 months and older in the United States should receive a COVID-19 primary series vaccination for the prevention of COVID-19. This attached provider guidance has expanded the age range to 6 months-11 years of age accordingly.
A summary of the most recent changes to the Guidance for the New York State COVID-19 Vaccination Program: Vaccination of Children Ages 6 Months to 11 Years is outlined below:
- Update as of June 18, 2022: Everyone ages 6 months and older in the United States should receive a COVID-19 primary series vaccination for the prevention of COVID-19.
- On June 18, 2022, the CDC authorized BOTH the Pfizer-BioNTech COVID-19 vaccine for use as a 3-dose primary series in children 6 months through 4 years of age, AND the Moderna COVID-19 vaccine for use as a 2-dose primary series in individuals 6 months through 5 years of age.
- Additionally, on June 18, 2022, the CDC updated the COVID-19 vaccine schedule for those eligible to receive a COVID-19 vaccine, by age, immunocompetency status and vaccine product.
- The CDC’s interim clinical considerations note that children ages 6 months–4 years who receive different mRNA products for the first 2 doses of an mRNA COVID-19 vaccine series should follow a 3-dose schedule. A third dose of either mRNA vaccine should be administered at least 8 weeks after the second dose to complete the 3-dose primary series.
- There are special considerations for the immunocompetent population for an extended interval of 3-8 weeks between Dose 1 & 2 depending on the vaccine product. The moderately & severely immunocompromised have a set interval of 3 weeks or 4 weeks between Dose 1 & 2.
- Individuals should receive the recommended age-appropriate vaccine dosage based on their age on the day of vaccination. According to the CDC, if a child moves from a younger group to an older age group during the primary series or between primary series and receipt of a booster dose, they should receive the vaccine product and dosage for their older age group for all subsequent doses.
- Regarding preterm infants (infants born before 37 weeks’ gestation) as a special population, regardless of birth weight, should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance as for full-term infants and children.
Attached are updated documents:
- Guidance for the New York State COVID-19 Vaccination Program: Vaccination of Children Ages 6 Months to 11 Years
- Information for Health Care Professionals about the Screening Checklist for Administration of the Pfizer-BioNTech COVID-19 Vaccine for Children Ages 6 Months to 11 Years
- COVID-19 Immunization Screening and Consent Form: Children and Adolescents Ages 6 Months to 11 Years
- Information for Health Care Professionals about the Screening Checklist for the COVID-19 Vaccine for Moderately to Severely Immunocompromised People
- COVID-19 Immunization Screening and Consent Form for Moderately to Severely Immunocompromised People
Thank you for your ongoing participation in the COVID-19 Vaccination Program.
The NYS COVID-19 Vaccine Team